Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CONIUNCTA is a German biotechnology company specializing in the development and production of high-performance plant extracts and active ingredients for the cosmetics, food, and pharmaceutical industries. The company utilizes its proprietary AI-controlled Adaptive Vacuum Extraction (AVE®) technology, which isolates heat-sensitive phyto-actives while maintaining high sustainability and energy efficiency. With a portfolio of over 400 organic and conventional extracts, CONIUNCTA provides standardized and customized ingredients to a global clientele ranging from boutique brands to large corporations. Additionally, the company offers the ANALYSUS cloud platform, a digital solution that automates the generation of regulatory-compliant Certificates of Analysis (CoA) to streamline quality assurance for its partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CONIUNCTA.